Independent Research GmbH Upgrades Pfizer (PFE) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Wall St edges lower as chips fall; markets assess big bank earnings
- Oil prices mixed as US-Russia diesel deal hopes offset Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Tweet
Share
E-mailGet Alerts PFE Hot Sheet
Price: $28.31 -0.32%
Rating Summary:
14 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 17 | New: 33
Rating Summary:
14 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 17 | New: 33
Join SI Premium – FREE
Independent Research GmbH analyst Tobias Gottschalt upgraded Pfizer (NYSE: PFE) from Hold to Buy with a price target of $54.00 (from $51.00).
For an analyst ratings summary and ratings history on Pfizer click here. For more ratings news on Pfizer click here.
Shares of Pfizer closed at $49.02 yesterday.
You May Also Be Interested In
- Fastenal (FAST) PT Raised to $51 at DA Davidson
- Scotiabank Upgrades ProLogis (PLD) to Sector Outperform
- MSC Industrial (MSM) PT Raised to $155 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT Change, Hot Upgrades, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
